The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
Michael Dreher(American Thoracic Society), Nikolaus Marx(RWTH Aachen University), Tobias Müller(Heidelberg University), Sebastian Lemmen(Universitätsklinikum Aachen), Johannes Bickenbach(RWTH Aachen University), Bojan Hartmann(Universitätsklinikum Aachen), Paul Balfanz(RWTH Aachen University), Gernot Marx(RWTH Aachen University), Dirk Müller‐Wieland(Universitätsklinikum Aachen), Jörg Christian Brokmann, Christian Cornélissen(RWTH Aachen University), Ayham Daher(RWTH Aachen University), Michael Kleines(RWTH Aachen University), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alexander Kersten
Cited by 258
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
|Critical Care|2013|1.4k
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
|The Lancet Respiratory Medicine|2020|864